Angiotensin Converting Enzyme Inhibitors and Diabetic Nephropathy.

BMJ
doi 10.1136/bmj.304.6823.327
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy

Hypertension
Internal Medicine
2003English

Angiotensin-I Converting Enzyme Polymorphism and Diabetic Nephropathy in North India

International Journal of Human Genetics
Genetics
2005English

Angiotensin Converting Enzyme (ACE) Inhibitors

Annual Review of Pharmacology and Toxicology
ToxicologyPharmacology
1982English

Dosage of Angiotensin Converting Enzyme Inhibitors

BMJ
1995English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Angioedema, Angiotensin Converting Enzyme Inhibitors, and Angiotensin Receptor Blocking Drugs

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2007English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Angiotensin Converting Enzyme Inhibitors for Cancer Treatment?

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2004English

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy